Jackson Creek Investment Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jackson Creek Investment Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-53,116	Closed	-$713K	–	376
2023 Q1	$713K	Sell	53,116 -16	-0%	-$277	0.3%	188
2022 Q4	$657K	Sell	53,132 -4,264	-7%	-$60.4K	0.29%	193
2022 Q3	$801K	Sell	57,396 -86	-0.1%	-$1.39K	0.37%	134
2022 Q2	$733K	Sell	57,482 -4,703	-8%	-$75.3K	0.3%	189
2022 Q1	$1.01M	Buy	62,185 +2,629	+4%	+$41.2K	0.37%	146
2021 Q4	$970K	Buy	+59,556	New	+$1M	0.35%	162

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Jackson Creek Investment Advisors's ICPT Position: Q2 2023 in Review

Jackson Creek Investment Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 53,116 shares — an estimated $713K sold.

Jackson Creek Investment Advisors first reported a position in ICPT in Q4 2021 and held it in 6 quarters. The position peaked at $1.01M in Q1 2022. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

Jackson Creek Investment Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Jackson Creek Investment Advisors sold 53,116 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $713K.
Jackson Creek Investment Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2021 and held it in 6 quarters.
Jackson Creek Investment Advisors's Intercept Pharmaceuticals, Inc. position peaked at $1.01M in Q1 2022.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.